Last year, Sonoma Pharmaceuticals Inc generated 17.68M USD for its biggest-performing segment, Human Care. The Europe made the largest contribution, accounting for 6.90M USD last year. For the latest quarter, Sonoma Pharmaceuticals Inc reported the revenue of 5.97M USD for the period ending 2026-06-30, which came from the top-performing segment, Human Care. United States contributed the highest revenue, at 2.43M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Human Care

Animal Care

Service and Royalty

Service

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Human Care

17.68M(90.54%)

12.08M(84.54%)

10.11M(79.39%)

9.43M(71.02%)

9.01M(71.35%)

15.32M(82.22%)

15.69M(87.49%)

15.91M(83.88%)

Animal Care

1.85M(9.46%)

1.65M(11.57%)

2.20M(17.30%)

2.50M(18.84%)

3.17M(25.10%)

3.20M(17.18%)

2.09M(11.66%)

1.97M(10.38%)

Service and Royalty

--(--)

556.00K(3.89%)

422.00K(3.31%)

1.35M(10.14%)

449.00K(3.56%)

--(--)

Service

--(--)

112.00K(0.60%)

151.00K(0.84%)

1.09M(5.74%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

Europe

United States

Asia

Latin America

Rest of the world

Europe

Asia

Europe and Rest of the World

Service Revenues

Product license fees and royalties

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Europe

6.90M(35.35%)

--(--)

United States

5.67M(29.05%)

2.61M(18.27%)

3.06M(24.01%)

3.43M(25.83%)

3.81M(30.15%)

5.42M(29.09%)

7.99M(44.57%)

9.04M(47.65%)

8.37M(53.45%)

6.58M(51.31%)

4.37M(31.17%)

1.98M(15.22%)

1.41M(11.05%)

6.84M(44.28%)

4.72M(37.01%)

Asia

2.90M(14.85%)

--(--)

Latin America

2.37M(12.15%)

2.96M(20.73%)

1.73M(13.55%)

2.38M(17.96%)

2.10M(16.59%)

5.98M(32.08%)

3.77M(21.05%)

3.96M(20.89%)

3.01M(19.20%)

1.30M(10.13%)

4.96M(35.41%)

5.05M(38.88%)

3.76M(29.54%)

5.89M(38.09%)

5.19M(40.73%)

Rest of the world

1.68M(8.59%)

875.00K(6.12%)

872.00K(6.85%)

959.00K(7.23%)

--(--)

Europe

--(--)

5.52M(38.65%)

4.78M(37.54%)

4.05M(30.52%)

--(--)

Asia

--(--)

2.32M(16.22%)

2.30M(18.04%)

2.45M(18.47%)

--(--)

Europe and Rest of the World

--(--)

6.73M(53.26%)

7.23M(38.83%)

6.16M(34.38%)

4.88M(25.72%)

4.28M(27.35%)

4.08M(31.80%)

3.71M(26.43%)

2.91M(22.38%)

2.05M(16.08%)

1.85M(12.00%)

1.95M(15.28%)

Service Revenues

--(--)

1.09M(5.74%)

--(--)

868.00K(6.77%)

981.00K(7.00%)

3.06M(23.52%)

5.51M(43.33%)

869.00K(5.62%)

891.00K(6.99%)

Product license fees and royalties

--(--)